JVTSX | VEXPX | JVTSX / VEXPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 57 years | - |
Gain YTD | 11.920 | 9.311 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.25B | 22.6B | 14% |
Annual Yield % from dividends | 0.00 | 0.48 | - |
Returns for 1 year | 15.60 | 19.96 | 78% |
Returns for 3 years | -24.03 | -18.05 | 133% |
Returns for 5 years | 4.28 | 18.90 | 23% |
Returns for 10 years | 23.61 | 16.53 | 143% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TQSIX | 23.84 | 0.04 | +0.17% |
T. Rowe Price Integrated US SMCC Eq I | |||
RYBHX | 56.41 | 0.06 | +0.11% |
Rydex S&P MidCap 400 Pure Growth H | |||
ACCLX | 16.67 | 0.01 | +0.06% |
American Century Mid Cap Value C | |||
FIJYX | 36.99 | 0.02 | +0.05% |
Fidelity Advisor Biotechnology Z | |||
NWHMX | 9.91 | -0.03 | -0.30% |
Nationwide Bailard Intl Eqs R6 |